ZA201107415B - Sparc angiogenic domain and methods of use - Google Patents

Sparc angiogenic domain and methods of use

Info

Publication number
ZA201107415B
ZA201107415B ZA2011/07415A ZA201107415A ZA201107415B ZA 201107415 B ZA201107415 B ZA 201107415B ZA 2011/07415 A ZA2011/07415 A ZA 2011/07415A ZA 201107415 A ZA201107415 A ZA 201107415A ZA 201107415 B ZA201107415 B ZA 201107415B
Authority
ZA
South Africa
Prior art keywords
methods
angiogenic domain
sparc angiogenic
sparc
domain
Prior art date
Application number
ZA2011/07415A
Other languages
English (en)
Inventor
Vuong Trieu
Neil P Desai
Daniel Knauer
Original Assignee
Abraxis Biosciences Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abraxis Biosciences Llc filed Critical Abraxis Biosciences Llc
Publication of ZA201107415B publication Critical patent/ZA201107415B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Cardiology (AREA)
  • Physics & Mathematics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
ZA2011/07415A 2009-03-11 2011-10-10 Sparc angiogenic domain and methods of use ZA201107415B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15932209P 2009-03-11 2009-03-11
PCT/US2010/027041 WO2010105097A2 (en) 2009-03-11 2010-03-11 Sparc angiogenic domain and methods of use

Publications (1)

Publication Number Publication Date
ZA201107415B true ZA201107415B (en) 2012-06-27

Family

ID=42729116

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2011/07415A ZA201107415B (en) 2009-03-11 2011-10-10 Sparc angiogenic domain and methods of use

Country Status (13)

Country Link
US (2) US20120087910A1 (https=)
EP (1) EP2405932A4 (https=)
JP (1) JP2012520081A (https=)
KR (2) KR20130043242A (https=)
CN (2) CN103724417A (https=)
AU (1) AU2010224031B2 (https=)
BR (1) BRPI1009457A2 (https=)
CA (1) CA2755109A1 (https=)
IL (2) IL215089A0 (https=)
MX (1) MX2011009478A (https=)
NZ (1) NZ595528A (https=)
WO (1) WO2010105097A2 (https=)
ZA (1) ZA201107415B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013522235A (ja) * 2010-03-11 2013-06-13 アブラクシス バイオサイエンス リミテッド ライアビリティー カンパニー Ｓｐａｒｃ血管新生領域及びその使用法
US8628554B2 (en) 2010-06-13 2014-01-14 Virender K. Sharma Intragastric device for treating obesity
US9526648B2 (en) 2010-06-13 2016-12-27 Synerz Medical, Inc. Intragastric device for treating obesity
US10010439B2 (en) 2010-06-13 2018-07-03 Synerz Medical, Inc. Intragastric device for treating obesity
US10420665B2 (en) 2010-06-13 2019-09-24 W. L. Gore & Associates, Inc. Intragastric device for treating obesity
US10779980B2 (en) 2016-04-27 2020-09-22 Synerz Medical, Inc. Intragastric device for treating obesity
CN120361186B (zh) * 2025-04-15 2025-12-30 北京大学口腔医学院 一种促进血管生成和组织再生的药物组合物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002000677A1 (en) * 2000-06-07 2002-01-03 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
AU2006237613A1 (en) * 2005-02-18 2006-10-26 Abraxis Bioscience, Inc. Q3 SPARC deletion mutant and uses thereof
US8440625B2 (en) * 2006-06-26 2013-05-14 University Of British Columbia Secreted protein acidic and rich in cysteine (SPARC) as chemotherapeutic sensitizers
ES2389828T3 (es) * 2007-04-13 2012-11-02 Abraxis Bioscience, Inc. Composiciones que comprenden polipéptidos SPARC

Also Published As

Publication number Publication date
CA2755109A1 (en) 2010-09-16
KR20110139256A (ko) 2011-12-28
BRPI1009457A2 (pt) 2016-03-01
CN102482334A (zh) 2012-05-30
AU2010224031A1 (en) 2011-10-06
EP2405932A2 (en) 2012-01-18
KR20130043242A (ko) 2013-04-29
EP2405932A4 (en) 2012-08-22
US20140094416A1 (en) 2014-04-03
CN103724417A (zh) 2014-04-16
IL228795A0 (en) 2013-12-31
WO2010105097A2 (en) 2010-09-16
JP2012520081A (ja) 2012-09-06
US20120087910A1 (en) 2012-04-12
MX2011009478A (es) 2011-11-18
IL215089A0 (en) 2011-11-30
NZ595528A (en) 2013-10-25
WO2010105097A3 (en) 2010-11-04
AU2010224031B2 (en) 2013-05-02
AU2010224031A2 (en) 2011-10-20
WO2010105097A8 (en) 2011-05-26

Similar Documents

Publication Publication Date Title
IL272376A (en) Polycyclic compounds and methods of using them
EP2411024A4 (en) Variants of factor viii and associated methods of use
IL213971A0 (en) Modular dna-binding domains and methods of use
IL209754A0 (en) Diazacarbazoles and methods of use
EP2262450A4 (en) IMPLANTS AND METHODS OF USE
GB0808557D0 (en) Sampling devices and methods of use
EP2464227A4 (en) COMPOUNDS AND METHODS OF USE
IL236830A0 (en) Diazahomoredene derivatives and methods of using them
GB2479020B (en) Toothbrush and method of use
IL210582A0 (en) Deuterated benzylbenzene derivatives and methods of use
IL215251A0 (en) Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
ZA201104463B (en) Compounds and methods of use
IL205977A0 (en) 5-anilinoimidazopyridines and methods of use
EP2262754A4 (en) MINOCYCLINE COMPOUNDS AND METHODS OF USE THEREOF
IL209548A0 (en) Diazacarbazoles and methods of use
IL219650A0 (en) Surgical needle coatings and methods
IL206125A0 (en) Azaindolizines and methods of use
IL219652A0 (en) Surgical needle coatings and methods
ZA201107415B (en) Sparc angiogenic domain and methods of use
IL219651A0 (en) Surgical needle coatings and methods
PL2498613T3 (pl) Kompozycje biobójcze i sposoby ich stosowania
IL214762A0 (en) Modifications of cupredoxin derives peptides and methods of use thereof
EP2427129A4 (en) DEVICES AND METHODS FOR MODIFYING FABRICS
EP2421542A4 (en) SPUME VIRUS VECTORS AND METHODS OF USE
EP2381950A4 (en) COMPOSITIONS AND METHOD FOR THEIR USE